Generic drugs surge in Brazil as patents expire

PR-Inside has published a note on Generic Drugs Market in Brazil (2007-2011), a Companies and Markets report. The report itself mentions that emerging economic power Brazil is stamping its identity strongly upon the generic drugs industry, and that major generic players are heading to Brazil to make and sell their drugs there.

The generic drugs market was valued at over US$ 1 billion in 2006, aided by the expiration of patents governing several blockbuster drugs and government policy that generics should be prescribed wherever possible. Although the market is currently still dominated by local generic manufacturers; however, foreign firms are rapidly gaining ground.